Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma

Blood Cancer J. 2014 May 9;4(5):e213. doi: 10.1038/bcj.2014.33.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Cohort Studies
  • Disease-Free Survival
  • Female
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / therapy*
  • Outpatients
  • Survival Rate
  • Transplantation Conditioning / methods